small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (164)
  • Capabilities (33)
  • Experience (16)
  • Insights & News (618)
  • Other Results (26)

Professionals 164 results

Nimalka Wickramasekera
Nimalka Wickramasekera
Partner
  • Los Angeles, 
  • Silicon Valley
Email
+1 213-615-1819
vCard

Partner

  • Los Angeles
  • Silicon Valley
T. Reed Stephens
T. Reed Stephens
Partner
  • Washington, DC
Email
+1 202-282-5795
vCard

Partner

  • Washington, DC
Charles B. Klein
Charles B. Klein
Partner
  • Washington, DC
Email
+1 202-282-5977
vCard

Partner

  • Washington, DC
View All Professionals

Capabilities 33 results

Industry

Medical Devices

The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative healthcare landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Healthcare & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions....Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Practice Area

Trade Secrets, Non Competes & Restrictive Covenants

In today’s fast-paced, global marketplace, the theft of trade secrets and other confidential information is an all-too-common risk. Our team helps clients navigate this complex landscape with strategies that are both comprehensive and scalable—designed to prevent issues before they arise and respond effectively when they do....Read more

Experience 16 results

Experience

|

April 1, 2025

PDI Technologies Acquisition of P97 Networks

On April 1, 2025, PDI Technologies acquired P97 Networks, a Houston-based provider of mobile commerce and digital marketing solutions for the convenience retail, automotive, and fuel markets. P97's cloud-based platform enables secure mobile payments and loyalty programs, serving major fuel brands like CITGO, ExxonMobil, and Shell. The acquisition aims to enhance PDI's digital engagement ecosystem, expanding capabilities in mobile payments, loyalty, and omnichannel consumer experiences across connected devices....Read more

Experience

|

November 25, 2024

Creative Global Technologies Closes On Initial Public Offering

Winston & Strawn LLP represented Benjamin Securities, Inc., as underwriters' counsel, in connection with Creative Global Technology Holdings Limited, a Hong Kong-based company sourcing and reselling recycled consumer electronic devices, in the closing of its initial public offering of 1,250,000 ordinary shares at a price of $4.00 per share, generating total gross proceeds of $5,750,000. The offering closed on November 27,2024. In addition, the company has granted the underwriters an option, within 45-days option to purchase up to 187,500 additional ordinary shares at the public offering price, less underwriting discounts, to cover any over-allotments....Read more

Experience

|

November 11, 2024

Court Square Capital Partners in its Definitive Agreement to Sell Advanced Diabetes Supply Group for US$1.1B

A team led by Craig Godshall and Matthew Schlosser represented Court Square Capital Partners, a New York-based leading middle-market private equity company, in its entry into a definitive agreement to sell Advanced Diabetes Supply® Group, a California-based national distributor of Durable Medical Equipment specializing in diabetes supplies, to Cardinal Health for US$1.1B. This sale will allow ADSG to continue to expand its reach and enhance the way it serves its approximately 500,000 patients nationwide with advances in in-home delivery of diabetes products including continuous glucose monitoring devices and other testing supplies....Read more
View All Experience

Insights & News 618 results

Competition Corner

|

December 23, 2025

|

4 Min Read

The Continuing Expansion of Algorithmic Software Laws – Best Practices for Companies in an Evolving Landscape

New York recently expanded its algorithmic pricing laws, now requiring retailers to disclose when prices are set with algorithmic software based on consumers’ personal data.The so-called practice of surveillance pricing entails adjusting prices charged for goods and services according to monitored personal data.

Competition Corner

|

December 17, 2025

|

3 Min Read

Antitrust Remedies in United States v. Google: AI and the Evolving Search Market

Following the August 5, 2024, decision in United States v. Google where the D.C. District Court found Google to be a monopolist, Judge Amit Mehta issued what would end up being the first remedies opinion on September 2, 2025. The decision establishes a six-year framework designed to promote competition in the general search engine market. 

Product Liability & Mass Torts Digest

|

August 22, 2025

|

5 Min Read

District Court Recognizes Loper Bright Does Not Undermine Basis for Express-Preemption Defense in Medical Device Cases

In what appears to be the first case to consider the issue, an Eastern District of Missouri court recently rejected the argument that the Supreme Court’s Loper Bright Enterprises v. Raimondo decision overruling Chevron deference undermines the basis for express preemption in medical device cases.

 

View All Insights & News

Other Results 26 results

Law Glossary

What Is Internet of Things (IoT) Law?

The Internet of Things (IoT) area of the law relates to internet-connected devices, from smartphones to thermostats, which may collect user data and conduct analytics. In 2015, the Federal Trade Commission (FTC) issued guidelines on best practices and recommendations for companies providing home, wearable, and other personal connected devices. The FTC has recommended industry self-regulation as well as minimal collection and retention of consumer data in relation to IoT devices. The Commission also encourages companies to offer consumers data usage options and data sharing notifications....Read more

Law Glossary

What Is the FDA?

The FDA stands for the Food and Drug Administration. It is a federal agency charged with protecting the public by regulating the safety and security of drugs, biological products, veterinary medications, and medical devices. FDA responsibilities also cover the safety of: foods for U.S. consumers, cosmetics, animal feed, and radiation-emitting products. Various rules may be established and enforced by the agency in response to U.S. laws or presidential executive orders....Read more

Law Glossary

What Is Tracking and Monitoring Law?

Tracking and monitoring law is related to the rights of individuals and often addressed through state legislation. Tracking law looks at when and how individuals can be tracked through GPS devices and location services. Employers have the right to track company vehicles through GPS devices but cannot track an employee’s vehicle in many states without employee consent. (A written policy on tracking and monitoring may be required, with the policies stating a business purpose for the activities.) Tracking apps on mobile phones can continue to broadcast an employee’s location even after work hours. That is why companies must ensure they are satisfying employees’ expectations of privacy....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising